Original Research Online Publishing Date: | ||||||||||||
A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease Dushyant Shantilal Patel, Nirav Rasiklal Patel, Jagdishkumar Virabhai Patel, Avani Bipinchandra Chavda.
|
How to Cite this Article |
Pubmed Style Patel DS, Patel NR, Patel JV, Chavda AB. A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease. Natl J Physiol Pharm Pharmacol. 2022; 12(5): 680-683. doi:10.5455/njppp.2022.12.04162202211042022 Web Style Patel DS, Patel NR, Patel JV, Chavda AB. A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease. https://www.njppp.com/?mno=10989 [Access: March 14, 2024]. doi:10.5455/njppp.2022.12.04162202211042022 AMA (American Medical Association) Style Patel DS, Patel NR, Patel JV, Chavda AB. A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease. Natl J Physiol Pharm Pharmacol. 2022; 12(5): 680-683. doi:10.5455/njppp.2022.12.04162202211042022 Vancouver/ICMJE Style Patel DS, Patel NR, Patel JV, Chavda AB. A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease. Natl J Physiol Pharm Pharmacol. (2022), [cited March 14, 2024]; 12(5): 680-683. doi:10.5455/njppp.2022.12.04162202211042022 Harvard Style Patel, D. S., Patel, . N. R., Patel, . J. V. & Chavda, . A. B. (2022) A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease. Natl J Physiol Pharm Pharmacol, 12 (5), 680-683. doi:10.5455/njppp.2022.12.04162202211042022 Turabian Style Patel, Dushyant Shantilal, Nirav Rasiklal Patel, Jagdishkumar Virabhai Patel, and Avani Bipinchandra Chavda. 2022. A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease. National Journal of Physiology, Pharmacy and Pharmacology, 12 (5), 680-683. doi:10.5455/njppp.2022.12.04162202211042022 Chicago Style Patel, Dushyant Shantilal, Nirav Rasiklal Patel, Jagdishkumar Virabhai Patel, and Avani Bipinchandra Chavda. "A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 680-683. doi:10.5455/njppp.2022.12.04162202211042022 MLA (The Modern Language Association) Style Patel, Dushyant Shantilal, Nirav Rasiklal Patel, Jagdishkumar Virabhai Patel, and Avani Bipinchandra Chavda. "A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease." National Journal of Physiology, Pharmacy and Pharmacology 12.5 (2022), 680-683. Print. doi:10.5455/njppp.2022.12.04162202211042022 APA (American Psychological Association) Style Patel, D. S., Patel, . N. R., Patel, . J. V. & Chavda, . A. B. (2022) A cross-sectional study to evaluate etiopathogenesis, clinical features, complications, and treatment of patients of chronic kidney disease. National Journal of Physiology, Pharmacy and Pharmacology, 12 (5), 680-683. doi:10.5455/njppp.2022.12.04162202211042022 |